Most patients on Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease achieved sustained clinical remission and endoscopic response at two years
Eli Lilly and Company (NYSE: LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of ...
Guardian Capital LP receives two Fundata FundGrade A+® Awards for 2024
Guardian Capital LP (“Guardian Capital”) is proud to announce that two of its mutual funds, the GC One Fixed Income Portfolio and the Guardian Canadian Focused Equity Fund (each a “Fund” and ...
Camden Property Trust Announces Fourth Quarter 2024 Operating Results, 2025 Financial Outlook, and First Quarter 2025 Dividend
Camden Property Trust (NYSE:CPT) (the "Company") announced today operating results for the three and twelve months ended December 31, 2024. Net Income Attributable to Common ...
Lumentum Announces Fiscal Second Quarter 2025 Financial Results
Lumentum Holdings Inc. ("Lumentum" or the "Company") today reported results for its fiscal second quarter ended December 28, 2024. "In the second quarter, we exceeded ...